在社区和门诊环境中实践teclistamab管理的经验:血液学提供者的混合方法研究
Benjamin Derman1, Jane Jijun Liu2, Nicholas Bouchard3
1University of Chicago Medical Center, Chicago, IL, USA.
Current medical research and opinion
|February 18, 2026
概括
门诊teclistamab逐步增加剂量 (SUD) 是可行的在社区实践为选定的患者. 这项研究详细介绍了成功的门诊teclistamab SUD的现实世界模型和实施因素.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 德克利斯塔马布是一种用于治疗多发性骨髓瘤的双特异性抗体.
- 升级剂量 (SUD) 是teclistamab的一个关键的给药计划.
- 了解现实世界的实施对于优化患者护理至关重要.
研究的目的:
- 描述德克利斯塔马布升级剂量 (SUD) 的现实世界护理模型.
- 在社区实践中确定成功实施的考虑因素.
- 为了评估teclistamab的门诊SUD模型.
主要方法:
- 混合方法研究利用调查,采访和圆桌讨论.
- 参与了具有现实世界 teclistamab 经验的美国提供商.
- 收集了关于SUD模型,不良事件管理和护理过渡的数据.
主要成果:
- 有38个实践参与; 76%是基于社区的.
- 53%的患者使用门诊SUD,26%的患者使用住院SUD,21%的患者被转诊.
- 关键的门诊SUD标准包括护理人员的支持和接近;住院患者的触发因素包括毒性和生命体征异常.
结论:
- 门诊teclistamab SUD在适当选择的患者中成功实施.
- 洞察力向提供者提供有关实施门诊SUD模型的信息.
- 旨在改善患者的接入,同时降低成本和资源负担.
更多相关视频
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
19.0K
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
54.1K
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
258
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
Therapeutic Drug Monitoring: Overview and Classification
395
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
395
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)